CAD 0.03
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | -1.89 Million | -2.24 Million | -2.61 Million | - |
Net Income | -2.76 Million | -2.79 Million | -4.25 Million | - |
Depreciation & Amortization | 318.39 Thousand | 316.5 Thousand | 281.61 Thousand | - |
Deferred income taxes | - | - | 11.79 Thousand | - |
Stock-based compensation | 154.2 Thousand | 503.15 Thousand | 1.04 Million | - |
Change in working capital | 118.45 Thousand | -250.63 Thousand | 261.81 Thousand | - |
Other non-cash items | 890.28 Thousand | -18.43 Thousand | 44.77 Thousand | - |
Investing Cash Flow | 1.1 Million | 1.86 Million | -3.69 Million | - |
Investments in PPE | -36.12 Thousand | -49.48 Thousand | -48.35 Thousand | - |
Acquisitions | - | 2 Million | -100 Thousand | - |
Investment purchases | -354.52 Thousand | -32.93 Thousand | -3.5 Million | - |
Sales/Maturities of investments | 1.5 Million | 2 Million | -12.24 Thousand | - |
Other Investing Activities | -8955.00 | -2.04 Million | -33.13 Thousand | - |
Financing Cash Flow | 668.52 Thousand | 21 Thousand | 7.06 Million | 10.00 |
Debt repayment | -51.47 Thousand | -49.5 Thousand | - | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 720 Thousand | 21 Thousand | 7.06 Million | 10.00 |
Other Financing Activities | -354.51 Thousand | - | - | - |
Accounts receivables | 303.72 Thousand | -355.49 Thousand | -5708.00 | - |
Accounts payables | -40.73 Thousand | 25.23 Thousand | 326.19 Thousand | - |
Inventory | -79.11 Thousand | - | -326.19 Thousand | - |
Other working capital | -65.41 Thousand | 79.62 Thousand | 267.52 Thousand | - |
Cash at beginning of period | 401.17 Thousand | 759.91 Thousand | 10.00 | - |
Cash at end of period | 283.38 Thousand | 401.17 Thousand | 759.91 Thousand | 10.00 |
Capital Expenditure | -36.12 Thousand | -49.48 Thousand | -48.35 Thousand | - |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | -117.79 Thousand | -358.74 Thousand | 759.9 Thousand | 10.00 |
Free Cash Flow | -1.93 Million | -2.29 Million | -2.66 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -719.34 Thousand | -624.68 Thousand | -2.76 Million | -1 Million | -513.17 Thousand | -1.08 Million |
Depreciation & Amortization | 82.04 Thousand | 79.87 Thousand | 318.39 Thousand | 79.42 Thousand | 79.65 Thousand | 79.76 Thousand |
Deferred income taxes | - | - | - | - | 151.72 Thousand | 271.36 Thousand |
Stock-based compensation | 2769.00 | - | 154.2 Thousand | -58.64 Thousand | 135.75 Thousand | 23.71 Thousand |
Change in working capital | -173.78 Thousand | 69.83 Thousand | 118.45 Thousand | 541.38 Thousand | -751.47 Thousand | 229.31 Thousand |
Other non-cash items | 356.57 Thousand | 113.81 Thousand | 890.28 Thousand | 147.88 Thousand | 1284.00 | -636.00 |
Investing Cash Flow | -12.91 Thousand | -32.16 Thousand | 1.1 Million | -15.5 Thousand | 474.06 Thousand | 487.01 Thousand |
Investments in PPE | -12.91 Thousand | -32.16 Thousand | -36.12 Thousand | -11.49 Thousand | 12.62 Thousand | -13.95 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -354.52 Thousand | -354.52 Thousand | - | - |
Sales/Maturities of investments | - | - | 1.5 Million | 311.94 Thousand | 500 Thousand | 500.97 Thousand |
Other Investing Activities | -1072.00 | - | - | 38.56 Thousand | -38.56 Thousand | -12.91 Thousand |
Financing Cash Flow | 369.37 Thousand | 690.08 Thousand | 668.52 Thousand | 373.52 Thousand | 275 Thousand | 20 Thousand |
Debt repayment | -382.29 Thousand | - | -51.47 Thousand | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 703 Thousand | 720 Thousand | 425 Thousand | 275 Thousand | 20 Thousand |
Other Financing Activities | -12.91 Thousand | - | -354.51 Thousand | - | - | - |
Accounts receivables | -6967.00 | 50.36 Thousand | 303.72 Thousand | 232.17 Thousand | -75.28 Thousand | 201.39 Thousand |
Accounts payables | -181.39 Thousand | 285.75 Thousand | -40.73 Thousand | 30.62 Thousand | -31.51 Thousand | -25.53 Thousand |
Inventory | 21.8 Thousand | -296.86 Thousand | -79.11 Thousand | - | -398.42 Thousand | 15.95 Thousand |
Other working capital | -7228.00 | 30.58 Thousand | -65.41 Thousand | 357.7 Thousand | -246.25 Thousand | 37.5 Thousand |
Cash at beginning of period | 459.64 Thousand | 283.38 Thousand | 401.17 Thousand | 55.76 Thousand | 202.94 Thousand | 178.36 Thousand |
Cash at end of period | 30.94 Thousand | 459.64 Thousand | 283.38 Thousand | 283.38 Thousand | 55.76 Thousand | 202.94 Thousand |
Capital Expenditure | -12.91 Thousand | -32.16 Thousand | -36.12 Thousand | -11.49 Thousand | 12.62 Thousand | -13.95 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -428.69 Thousand | 176.26 Thousand | -117.79 Thousand | 227.62 Thousand | -147.17 Thousand | 24.57 Thousand |
Free Cash Flow | -798.07 Thousand | -513.82 Thousand | -1.93 Million | -141.89 Thousand | -883.61 Thousand | -496.39 Thousand |
7709
IRIS
7438
ALRGR
EXPLEOSOL
SOFW